Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other…
16/05/2018 - 2 minutes
Parkinson’s
Major $115M Fundraising Fuels AI Drug Development
BenevolentAI has raised a massive second round of fundraising to expand the drug developing capabilities…
19/04/2018 - 2 minutes
AI Is Being Put to Work to Treat Parkinson’s Disease in the UK
The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to…
28/03/2018 - 2 minutes
Lundbeck Signs Near €1Bn Acquisition of Swiss Parkinson’s Biotech
Lundbeck is acquiring Prexton Therapeutics in a deal that could reach up to €905M if…
16/03/2018 - 2 minutes
This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases
Today we're in Ghent, Belgium, home to several successful biotechs, including Ablynx, to visit ADx…
16/03/2018 - 2 minutes
Two Proteins in the Brain Could Protect Against and Repair the Damage Caused by Parkinson’s
Researchers have found two proteins that could be used to treat Parkinson's disease patients by…
16/01/2018 - 3 minutes
New Gene Therapy for Parkinson’s will be Developed in the UK
Synpromics and UCL will collaborate to develop a gene therapy to treat Parkinson's disease that…
28/11/2017 - 2 minutes
German Diagnostics Firm Tackles Early Detection of Cancer, Alzheimer’s and Parkinson’s
Hummingbird Diagnostics has teamed up with Saarland University to develop molecular diagnostics that can detect…
16/11/2017 - 2 minutes
Scottish Scientists Could Hold the Key to Unlocking Parkinson’s Disease
A decade of work has culminated in researchers reconstructing a protein that is key to…
11/10/2017 - 3 minutes
Swiss Biotech Starts Phase II Trial to Treat Motor Symptoms of Parkinson’s
Prexton Therapeutics has launched a Phase II trial to test whether its drug foliglurax can treat…
10/07/2017 - 2 minutes
Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II
Prothena and Roche are advancing their Parkinson's antibody to Phase II, triggering a new milestone…
06/07/2017 - 2 minutes
UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval
UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its…
12/05/2017 - 2 minutes
